605 research outputs found
Minimally Invasive Mapping Guided Surgical Treatment of Atrial Fibrillation. Utopia or Near Future?
Isolation of the pulmonary veins has been used as surgical treatment for atrial fibrillation (AF) from the early 90s, as it was incorporated in the Maze procedure. With the evidence that triggers form this area can induce AF, the Maze III procedure has been adapted and modified towards a single lesion around the pulmonary veins for the treatment of paroxysmal and chronic AF in some centers. New ablation techniques with a diversity of energy sources further paved the way for less invasive procedures. Minimal invasive techniques to prevent major surgery may potentially make the treatment available for a patient population that do not have to undergo cardiac surgery for other reasons. Besides these technical developments, high density mapping can be used to identify the AF substrate in the individual patient and optimization of the treatment by local substrate guided ablation. This review aims to summarize the robotic and thoracoscopic techniques to isolate the pulmonary veins. Furthermore, it is discussed why pulmonary veins isolation may be effective in patients with chronic AF, and whether there is a role for mapping guided minimal invasive surgical treatment of AF in the near future
Megatrends in Healthcare: Review for the Swiss National Science Foundation’s National Research Programme 74 (NRP74) “Smarter Health Care”.
Objectives: In this paper, we present a review of some relevant megatrends in healthcare conducted as part of the Swiss National Science Foundation’s National Research Programme 74 (NRP74) “Smarter Health Care.” Our aim is to stimulate discussions about long-term tendencies underlying the current and future development of the healthcare system.
Methods: Our team—a multidisciplinary panel of researchers involved in the NRP74—went through an iterative process of internal consultations followed by a rapid literature review with the goal of reaching group consensus concerning the most relevant megatrends in healthcare.
Results: Five megatrends were identified, namely: 1) Socio-demographic shifts. 2) Broadening meaning of “health.” 3) Empowered patients and service users. 4) Digitalization in healthcare. 5) Emergence of new models of care. The main features of each megatrend are presented, drawing often on the situation in Switzerland as a paradigmatic example and adding reflections on the potential influence of the COVID19 pandemic on them.
Conclusion: Considering the long-term megatrends affecting the evolution of healthcare is important—amongst other things–to understand and contextualise the relevance and implications of innovative health services research results
Subclinical myasthenia gravis in thymomas
Background: A proportion of thymoma-patients without a history of myasthenia gravis (MG) before thymectomy, appears to have positive anti-AChR-antibodies in the serum. These subclinical MG-patients could be under diagnosed because analyzation of anti-AChR-antibodies in thymomas is not always performed in patients who did not experience neurological symptoms. The prevalence and long-term outcomes of subclinical MG are never described in literature yet.Methods: We retrospectively analyzed 398 consecutive patients who underwent a robotic-assisted thoracoscopic surgery at the Maastricht University Medical Center+ (MUMC+) between April 2004 and December 2018. In the MUMC+, a robotic approach is the standard surgical approach in patients with thymic diseases. Inclusion criteria were thymomas, thymectomy performed in the MUMC + with a follow-up of at least one year and age above 18 years old. Exclusion criteria were patients with thymic carcinomas, refused participation, or those who were lost to follow-up.Results: Of the 102 included thymoma-patients, 87 patients (85 %) were tested for anti-AChR-antibodies before thymectomy, of which 57 patients were diagnosed with clinical MG and seven subclinical MG-patients were found. Of the 15 patients who were not tested for anti-AChR-antibodies, four more subclinical MG-patients were discovered in the years after thymectomy. The median follow-up time was 62 months. In total, 11 subclinical MG-patients were found, with a mean age of 54 years and predominantly females (64 %). Ten subclinical MG patients (91 %) developed clinical-MG, within six years after thymectomy. Immunosuppressive drugs were prescribed in five patients. Four patients were diagnosed with a recurrence of the thymoma. No surgical mortality was reported. Two patients died due to a myasthenic crisis.Conclusions: The prevalence of subclinical MG in thymomas was found to be 10.8 %. One in four patients who experienced no neurological symptoms before thymectomy, appeared to have anti-AChR-antibodies and 91 % of these patients developed clinical MG within six years after the thymectomy. Analyzing anti-AChR-antibodies in the serum is recommended in all suspected thymomas before a thymectomy is performed
The nonmesonic weak decay of the hypertriton
The nonmesonic decay of the hypertriton is calculated based on a hypertriton
wavefunction and 3N scattering states, which are rigorous solutions of 3-body
Faddeev equations using realistic NN and hyperon-nucleon interactions. The
pion-exchange together with heavier meson exchanges for the transition is considered. The total nonmesonic decay rate is found to be 0.5%
of the free decay rate. Integrated as well as differential decay
rates are given. The p- and n- induced decays are discussed thoroughly and it
is shown that the corresponding total rates cannot be measured individually.Comment: 27 pages, 20 figures, revtex, submitted to Phys. Rev.
Identité de l'image de sport
L'image de sport et le mouvement depuis les premières chronophotographies. Les mises en scène du sport et le public. L'image de sport, un objet d'étude en devenir. Propositions d'outils d'analyse
Bioengineering of Improved Biomaterials Coatings for Extracorporeal Circulation Requires Extended Observation of Blood-Biomaterial Interaction under Flow
Extended use of cardiopulmonary bypass (CPB) systems is often
hampered by thrombus formation and infection. Part of these
problems relates to imperfect hemocompatibility of the CPB
circuitry. The engineering of biomaterial surfaces with genuine
long-term hemocompatibility is essentially virgin territory in
biomaterials science. For example, most experiments with the
well-known Chandler loop model, for evaluation of
blood-biomaterial interactions under flow, have been described for
a maximum duration of 2 hours only. This study reports a systematic
evaluation of two commercial CPB tubings, each with a
hemocompatible coating, and one uncoated control. The experiments
comprised (i) testing over 5 hours under flow, with human whole
blood from 4 different donors; (ii) measurement of essential blood
parameters of hemocompatibility; (iii) analysis of the luminal
surfaces by scanning electron microscopy and thrombin generation
time measurements. The dataset indicated differences in
hemocompatibility of the tubings. Furthermore, it appeared that
discrimination between biomaterial coatings can be made only after
several hours of blood-biomaterial contact. Platelet counting,
myeloperoxidase quantification, and scanning electron microscopy
proved to be the most useful methods. These findings are believed
to be relevant with respect to the bioengineering of
extracorporeal devices that should function in contact with blood
for extended time
Pion-Lambda-Sigma Coupling Extracted from Hyperonic Atoms
The latest measurements of the atomic level width in Sigma-hyperonic Pb atom
offer the most accurate datum in the region of low-energy Sigma-hyperon
physics. Atomic widths are due to the conversion of Sigma-nucleon into
Lambda-nucleon. In high angular momentum states this conversion is dominated by
the one-pion exchange. A joint analysis of the data of the scattering of
negative-Sigma on proton converting into a Lambda and a neutron and of the
atomic widths allows to extract a pseudovector pion-hyperon-Sigma coupling
constant of 0.048 with a statistical error of +-0.005 and a systematic one of
+-0.004. This corresponds to a pseudoscalar coupling constant of 13.3 with a
statistical uncertainty of 1.4 and a systematic one of 1.1.Comment: 12 pages, 1 figure, Use of Revtex.st
- …